Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
medac GmbH clinical trials
The registry lists 29 studies whose lead sponsor is medac GmbH or one of 1 company grouped under it. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 12, 2026.
Keep track of what changes. Save the medac GmbH studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to medac GmbH.
- medac GmbH22 studiesSame company
Something wrong?
- 7 studies →
Studies
Recruiting first, then most recently updated. Showing 29 of 29.
- Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.RecruitingNCT06239311Phase 3
- Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available TherapyRecruitingNCT04629833Phase 3
- Dose-range Finding Treosulfan-based ConditioningCompletedNCT01063647Phase 1/2
- PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type GlioblastomaTerminatedNCT03897491Phase 2
Sponsor listed in the registry: photonamic GmbH & Co. KG · First submitted after photonamic GmbH & Co. KG left medac GmbH
- Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan PharmacokineticsCompletedNCT05534620Phase 1
- Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host DiseaseActive, not recruitingNCT06075706Phase 2
- PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic LeukaemiaTerminatedNCT03156790Phase 2
- Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant DiseasesCompletedNCT02349906Phase 2
- Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)CompletedNCT00822393Phase 3
- Treosulfan-based Conditioning in Paediatric Patients With Haematological MalignanciesCompletedNCT02333058Phase 2
- 5-ALA Patch-PDT of Actinic Keratosis on the Upper ExtremitiesCompletedNCT03606122Phase 2
Sponsor listed in the registry: photonamic GmbH & Co. KG · First submitted after photonamic GmbH & Co. KG left medac GmbH
- Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic ArthritisCompletedNCT02052167Early Phase 1
- Evaluation of the Suitability of PD P 506 A in the PDT of Distal Subungual Onychomycosis (DSO) of the Great Toenail.CompletedNCT02355899Phase 2
Sponsor listed in the registry: photonamic GmbH & Co. KG · First submitted before photonamic GmbH & Co. KG left medac GmbH
- Fluorescence-guided Resection in Breast CancerTerminatedNCT01110954Phase 2
Sponsor listed in the registry: photonamic GmbH & Co. KG · First submitted before photonamic GmbH & Co. KG left medac GmbH
- Photodynamic Therapy of Actinic Keratoses With Alacare®CompletedNCT01571336
Sponsor listed in the registry: photonamic GmbH & Co. KG · First submitted before photonamic GmbH & Co. KG left medac GmbH
- Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant GliomasCompletedNCT02755142Phase 1/2
- Bioavailability in Patient With Psoriasis: Metoject Prefilled PenCompletedNCT02097173Phase 1
- Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)PatientCompletedNCT01871961Phase 1
- Urokinase Therapy in Patients With Diabetic Foot SyndromeTerminatedNCT00823225Phase 3
- Preference Methotrexate (MTX) Pre-filled Syringe Versus Pre-filled Pen in Rheumatoid Arthritis (RA)CompletedNCT01793259Phase 3
- Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic LeukaemiaTerminatedNCT01251809Phase 1/2
- Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic LeukaemiaCompletedNCT00784017Phase 3
- Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic AcidCompletedNCT00241670Phase 3
- Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia (ALL)CompletedNCT00983138Phase 2
- Urokinase Therapy in Diabetic Foot SyndromeCompletedNCT00537498Phase 2
- Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)CompletedNCT01063660Phase 2
- Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)CompletedNCT01062490Phase 2
- PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AKCompletedNCT00308867Phase 3
Sponsor listed in the registry: photonamic GmbH & Co. KG · First submitted before photonamic GmbH & Co. KG left medac GmbH
- Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AKCompletedNCT00308854Phase 3
Sponsor listed in the registry: photonamic GmbH & Co. KG · First submitted before photonamic GmbH & Co. KG left medac GmbH